Basic properties of calcium phosphate cement containing atelocollagen in its liquid or powder phases

Biomaterials

Volumn 19, Issue 7-9, 1998, Pages 707-715

  Miyamoto, Youji ^a   Ishikawa, Kunio ^b   Takechi, Masaaki ^a   Toh, Taketomo ^a   Yuasa, Tetsuya ^a   Nagayama, Masaru ^a   Suzuki, Kazuomi ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Atelocollagen; Bone substitute; Calcium phosphate cement; Collagen; Hydroxyapatite

Indexed keywords

ADHESION; BONE; COLLAGEN; COMPOSITION EFFECTS; PHOSPHATE MINERALS; TENSILE STRENGTH;

ATELOCOLLAGEN; CALCIUM PHOSPHATE;

BONE CEMENT;

ATELOCOLLAGEN; BONE CEMENT; CALCIUM PHOSPHATE; HYDROXYAPATITE;

ADHESION; ARTICLE; BIOCOMPATIBILITY; BONE PROSTHESIS; PRIORITY JOURNAL; TENSILE STRENGTH;

BIOCOMPATIBLE MATERIALS; BONE CEMENTS; CALCIUM PHOSPHATES; CHEMISTRY, PHYSICAL; COLLAGEN; MECHANICS; MICROSCOPY, ELECTRON, SCANNING; POWDERS; X-RAY DIFFRACTION;

EID: 0032053093     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(97)00186-5     Document Type: Article

References (34)

1. [1] Kent JN, Quinn JH, Zide MF, Guerra LR, Boyne PJ. Alveolar ridge augmentation using nonresorbable hydroxylapatite with or without autogenous cancellous bone. J Oral Maxillofac Surg 1983;41:629-42.
2. [2] Brook IM, Lamb DJ. The use of particulate and block forms of hydroxylapatite for alveolar augmentation. Int J Oral Maxillofac Implants 1987;2:85-9.
3. [3] Wittkampf ARM. Augmentation of the maxillary alveolar ridge with hydroxylapatite and fibrin glue. J Oral Maxillofac Surg 1988;46:1019-21.
4. [4] Wittkampf ARM. Fibrin glue as cement for HA-granules. J Craniomaxillofac Surg 1989;17:179-81.
5. [5] Mercier P, Huang H, Cholewa J, Djokovic S. A comparative study of the efficacy and morbidity of five techniques for ridge augmentation of the mandible. J Oral Maxillofac Surg 1992;50: 210-7.
6. [6] Brook IM, Lamb DJ. Management of the atrophic anterior maxilla by combined hydroxyapatite augmentation and vestibuloplasty: a pilot study. Br J Oral Maxillofac Surg 1991;29:5-8.
7. [7] el Deeb M, Roszkowski MT, Sauk J, el Hakim I, Sawk J. Extra-cranial and mandibular augmentation with hydroxyapatite-collagen in induced diabetic and nondiabetic rats. J Oral Maxillofac Surg 1991;49:165-70.
8. [8] Waite DE. Overview and historical perspective of oral reconstructive surgery. Oral Surg Oral Med Oral Pathol 1989;68:495-8.
9. [9] Flautre B, Pasquier G, Blary MC, Anselme K, Hardouin P. Evaluation of hydroxyapatite powder coated with collagen as an injectable bone substitute: microscopic study in rabbit. J Mater Sci Mater Med 1996;7:63-7.
10. [10] Miyata T, Taira T, Noishiki Y. Collagen engineering for biomaterial use. Clinical Materials 1992;9:139-48.
11. [11] Sugaya A, Minabe M, Hori T, Tatsumi J, Watanabe Y, Ikeda K, Numabe Y, Hayashi H, Kamoi K. Effects on wound healing of tricalcium phosphate -collagen complex implants in periodontal osseous defects in the dog. J Periodontal Res 1990;25:60-3.
12. [12] Sugaya A, Minabe M, Tamura T, Hori T, Watanabe Y. Effects on wound healing of hydroxyapatite -collagen complex implants in periodontal osseous defects in the dog. J Periodontal Res 1989;24: 284-8.
13. [13] Blumenthal NM. The effect of supracrestal tricalcium phosphate ceramic-microfibrillar collagen grafting on postsurgical soft tissue levels. J Periodontol 1988;59:18-22.
14. [14] Brown WE, Chow LC. Combinations of sparingly soluble calcium phosphates in slurries and paste as mineralizers and cements. U. S. Patent 1986; No. 4,612,053.
15. [15] Brown WE, Chow LC. A new calcium phosphate, water-setting cement. In: Brown PW. editor. Cements Research Progress, American Ceramic Society, Westerville OH, 1986:351-79.
16. [16] Chow LC. Development of self-setting calcium phosphate cements. J Ceram Soc Jpn 1991;99:954-64.
17. [17] Miyamoto Y, Ishikawa K, Takechi M, Toh T, Yoshida Y, Nagayama M, Kon M, Asaoka K. Tissue responses to fast setting calcium phosphate cement in bone. J Biomed Mater Res 1997; 37:457-64
18. [18] Miyamoto Y, Ishikawa K, Fukao H, Sawada M, Nagayama M, Kon M, Asaoka K. In vivo setting behaviour of fast-setting calcium phosphate cement. Biomaterials 1995;16:855-60.
19. [19] Miyamoto Y, Ishikawa K, Takechi M, Toh T, Yuasa T, Nagayama M, Asaoka K. Histological and compositional evaluations of three types of calcium phosphate cements when implanted in subcutaneous tissue immediately after mixing. J Biomed Mater Res, Applied Biomaterials: in press.
20. [20] Ishikawa K, Takagi S, Chow LC, Ishikawa Y, Eanes ED, Asaoka K. Behavior of a calcium phosphate cement in simulated blood plasma in vitro. Dent Mater 1994;10:26-32.
21. [21] Ishikawa K, Takagi S, Chow LC, Ishikawa Y. Properties and mechanisms of fast-setting calcium phosphate cements. J Mater Sci Mater Med 1995;6:528-33.
22. [22] Miyamoto Y, Ishikawa K, Takechi M, Yuasa M, Kon M, Nagayama M, Asaoka K. Non-decay type fast-setting calcium phosphate cement: setting behaviour in calf serum and its tissue response. Biomaterials 1996;17:1429-35.
23. [23] Takechi M, Miyamoto Y, Ishikawa K, Yuasa M, Nagayama M, Kon M, Asaoka K. Non-decay type fast-setting calcium phosphate cement using chitosan. J Mater Sci Mater Med 1996;7: 317-22.
24. [24] Ishikawa K, Miyamoto Y, Kon M, Nagayama M, Asaoka K. Non-decay type fast-setting calcium phosphate cement: Composite with sodium alginate. Biomaterials 1995;16:527-32.
25. [25] Cassella JP, Barber P, Catterall AC, Ali SY. A morphometric analysis of osteoid collagen fibril diameter in osteogenesis imperfecta. Bone 1994;15:329-34.
26. [26] Cohen SL, Zylberberg L, Sangalli A, Gomez LM, Mottes M. Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone. J Biol Chem 1994;269:14751-58.
27. [27] Banks E, Nakajima S, Shapiro LC, Tilevitz O, Alonzo JR, Chianelli RR. Fibrous apatite grown on modified collagen. Science 1977;198:1164-66.
28. [28] Ishikawa K, Asaoka K. Estimation of ideal mechanical strength and critical prosity of calcium phosphate cement. J Biomed Mater Res 1995; 29:1537-43.
29. [29] Masi L, Franchi A, Santucci M, Danielli D, Arganini L, Giannone V, Formigli L, Benvenuti S, Tanini A, Beghe F, Mian M, Brandi ML. Adhesion, growth, and matrix production by osteoblasts on collagen substrata. Calcif Tissue Int 1992;51:202-12.
30. [30] Lynch MP, Stein JL, Stein GS, Lian JB. The influence of type collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification on expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 1995;216:35-45.
31. [31] Andrianarivo AG, Robinson JA, Mann KG, Tracy RP. Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J Cell Physiol 1992;153:uuj256-65.
32. [32] Gilles JA, Carnes DL, Windeler AS. Development of an in vitro culture system for the study of osteoclast activity and function. J Endod 1994;20:327-31.
33. [33] Lindskog S, Pierce A. Spreading of dentinoclasts on various substrata in vitro. Scand J Dent Res 1988;96:310-16.
34. [34] de Bruijn JD, Bovell YP, Davies JE, van Blitterswijk CA. Osteoclastic resorption of calcium phosphates is potentiated in postosteogenic culture conditions. J Biomed Mater Res 1994;28:105-12.